Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1G93A ALS Mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sigma-1 Receptor is a Pharmacological Target to Promote Neuroprotection in the SOD1G93A ALS Mice
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-10
DOI
10.3389/fphar.2021.780588
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuroprotective Effects of Sigma 1 Receptor Ligands on Motoneuron Death after Spinal Root Injury in Mice
- (2021) Núria Gaja-Capdevila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Sigma 1 receptor as a therapeutic target for Amyotrophic Lateral Sclerosis
- (2020) Mireia Herrando‐Grabulosa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
- (2019) Ariel Ionescu et al. Cell Death & Disease
- Distal hereditary motor neuronopathy of the Jerash type is caused by a novel SIGMAR1 c.500A>T missense mutation
- (2019) Antonis Ververis et al. JOURNAL OF MEDICAL GENETICS
- Motor Neuron Susceptibility in ALS/FTD
- (2019) Audrey M. G. Ragagnin et al. Frontiers in Neuroscience
- Enhancement of ATP production ameliorates motor and cognitive impairments in a mouse model of MPTP−induced Parkinson's disease
- (2019) Hidaka Haga et al. NEUROCHEMISTRY INTERNATIONAL
- Glial Activation and Central Synapse Loss, but Not Motoneuron Degeneration, Are Prevented by the Sigma-1 Receptor Agonist PRE-084 in the Smn2B/− Mouse Model of Spinal Muscular Atrophy
- (2018) Clàudia Cerveró et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Autophagy as a common pathway in amyotrophic lateral sclerosis
- (2018) Dao K.H. Nguyen et al. NEUROSCIENCE LETTERS
- Neuregulin 1 Reduces Motoneuron Cell Death and Promotes Neurite Growth in an in Vitro Model of Motoneuron Degeneration
- (2018) Guillem Mòdol-Caballero et al. Frontiers in Cellular Neuroscience
- Sigma-1 receptor protects against endoplasmic reticulum stress-mediated apoptosis in mice with cerebral ischemia/reperfusion injury
- (2018) Xuemei Zhao et al. APOPTOSIS
- Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
- (2018) Ralf Reilmann et al. LANCET NEUROLOGY
- Proteostasis disturbance in amyotrophic lateral sclerosis
- (2017) Danilo B. Medinas et al. HUMAN MOLECULAR GENETICS
- Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
- (2017) Koji Abe et al. LANCET NEUROLOGY
- ER stress and the unfolded protein response in neurodegeneration
- (2017) Claudio Hetz et al. Nature Reviews Neurology
- Sigma 1 receptor activation modifies intracellular calcium exchange in the G93A hSOD1 ALS model
- (2017) Vedrana Tadić et al. NEUROSCIENCE
- Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
- (2017) Jordi Bruna et al. Neurotherapeutics
- Mitochondria‐associated membrane collapse is a common pathomechanism in SIGMAR1 ‐ and SOD1 ‐linked ALS
- (2016) Seiji Watanabe et al. EMBO Molecular Medicine
- Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration
- (2015) Nathalie Bernard-Marissal et al. BRAIN
- Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke
- (2014) Roman Urfer et al. STROKE
- Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation
- (2013) Marco Peviani et al. NEUROBIOLOGY OF DISEASE
- Lack of sigma-1 receptor exacerbates ALS progression in mice
- (2013) T.A. Mavlyutov et al. NEUROSCIENCE
- SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
- (2013) Yoko Ono et al. NEUROSCIENCE LETTERS
- Genetic Determinants of Amyotrophic Lateral Sclerosis as Therapeutic Targets
- (2012) Daryl A. Bosco et al. CNS & Neurological Disorders-Drug Targets
- Expression of wild-type human superoxide dismutase-1 in mice causes amyotrophic lateral sclerosis
- (2012) K. S. Graffmo et al. HUMAN MOLECULAR GENETICS
- Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N′-dimethyltryptamine forming enzyme, indole-N-methyl transferase
- (2012) T.A. Mavlyutov et al. NEUROSCIENCE
- Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
- (2012) Renzo Mancuso et al. Neurotherapeutics
- A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis
- (2011) Amr Al-Saif et al. ANNALS OF NEUROLOGY
- In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis
- (2011) FengFeng Tian et al. Autophagy
- Evolution of gait abnormalities in SOD1G93A transgenic mice
- (2011) Renzo Mancuso et al. BRAIN RESEARCH
- Electrophysiological analysis of a murine model of motoneuron disease
- (2011) Renzo Mancuso et al. CLINICAL NEUROPHYSIOLOGY
- Autophagy in Spinal Cord Motor Neurons in Sporadic Amyotrophic Lateral Sclerosis
- (2011) Shoichi Sasaki JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Sigma Receptor Agonist 2-(4-Morpholinethyl)1 Phenylcyclohexanecarboxylate (Pre084) Increases GDNF and BiP Expression and Promotes Neuroprotection after Root Avulsion Injury
- (2011) Clara Penas et al. JOURNAL OF NEUROTRAUMA
- XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy
- (2009) C. Hetz et al. GENES & DEVELOPMENT
- Selective sigma receptor agonist 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate (PRE084) promotes neuroprotection and neurite elongation through protein kinase C (PKC) signaling on motoneurons
- (2009) M.-S. Guzmán-Lenis et al. NEUROSCIENCE
- Review: Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials
- (2009) Albert C. Ludolph et al. Therapeutic Advances in Neurological Disorders
- Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
- (2008) B TURNER et al. PROGRESS IN NEUROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now